Ann: Pregnancy supplement distribution deal secured, page-7

The market needs to relate every distribution deal to more dollars in revenues imo.

We saw the 188% increase in revs last quarter and they know already from sales that revenues are expected to grow this quarter and for 2018!

If they grow at that rate with as promised lower staff costs then cash flow positive is not that far away.

With an EV of $2.5 to $3m how much value is attributed to the medicinal cannabis part of the business?